期刊
JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM
卷 26, 期 11-12, 页码 1141-1147出版社
WALTER DE GRUYTER GMBH
DOI: 10.1515/jpem-2013-0029
关键词
adipokine; adolescents; neopterin; non-alcoholic fatty liver disease; obesity
资金
- Scientific & Technological Research Council of Turkey (TUBITAK) [SBAG 111S016]
Aim: Nonalcoholic fatty liver disease (NAFLD) is associated with inflammation and increased risk of atherosclerosis. Neopterin is regarded as a biochemical marker of cell-mediated immunity, which is secreted by monocytes and macrophages, mainly in response to interferon-gamma. The aim of the present study was to investigate the serum neopterin levels in obese adolescents and compare the neopterin levels in patients with and without NAFLD and also with healthy controls. The second aim of the study was to research the possible relationship between neopterin levels and adipokines (leptin, adiponectin, resistin, and ghrelin). Methods: Ninety-three obese adolescents (39 with NAFLD, 54 without NAFLD) and 55 healthy controls were enrolled in the study. Serum levels of neopterin and adipokines were measured with high-performance liquid chromatography and sandwich enzyme-linked immunosorbent assay, respectively. Results: Serum neopterin levels were significantly higher in patients with NAFLD (3.20 +/- 0.09 nmol/L) than in their healthy peers (2.91 +/- 0.08 nmol/L) (p=0.020). Neopterin levels were positively correlated with leptin levels in obese patients (r=0.380, p<0.001) and in the group comprising all individuals (r=0.206, p<0.05). There was no correlation between neopterin concentrations and relative weight, alanin aminotransferase, adiponectin, resistin, and ghrelin levels. Conclusion: The serum neopterin levels were significantly higher in obese adolescents with fatty liver disease compared to controls, and this may be related to increased cell-mediated immunity in fatty liver disease.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据